Cargando…

Delaying aging is neuroprotective in Parkinson’s disease: a genetic analysis in C. elegans models

Aging is the greatest risk factor for the development of Parkinson’s disease (PD). However, the role of aging in the pathogenesis of PD is not known and it is currently uncertain why the symptoms take many decades to develop when inherited mutations that cause the disease can be present from birth....

Descripción completa

Detalles Bibliográficos
Autores principales:	Cooper, Jason F, Dues, Dylan J, Spielbauer, Katie K, Machiela, Emily, Senchuk, Megan M, Van Raamsdonk, Jeremy M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516561/ https://www.ncbi.nlm.nih.gov/pubmed/28725688 http://dx.doi.org/10.1038/npjparkd.2015.22

Ejemplares similares

Activation of the mitochondrial unfolded protein response promotes longevity and dopamine neuron survival in Parkinson’s disease models
por: Cooper, Jason F., et al.
Publicado: (2017)

Mitochondrial and Cytoplasmic ROS Have Opposing Effects on Lifespan
por: Schaar, Claire E., et al.
Publicado: (2015)

Resistance to Stress Can Be Experimentally Dissociated From Longevity
por: Dues, Dylan J, et al.
Publicado: (2019)

Multiple genetic pathways regulating lifespan extension are neuroprotective in a G2019S LRRK2 nematode model of Parkinson’s disease
por: Senchuk, Megan M., et al.
Publicado: (2021)

Aging causes decreased resistance to multiple stresses and a failure to activate specific stress response pathways
por: Dues, Dylan J., et al.
Publicado: (2016)

Targeting Mitochondrial Network Disorganization is Protective in C. elegans Models of Huntington’s Disease
por: Machiela, Emily, et al.
Publicado: (2021)

Mitochondrial unfolded protein response transcription factor ATFS-1 promotes longevity in a long-lived mitochondrial mutant through activation of stress response pathways
por: Wu, Ziyun, et al.
Publicado: (2018)

Disruption of mitochondrial dynamics increases stress resistance through activation of multiple stress response pathways
por: Machiela, Emily, et al.
Publicado: (2020)

Activation of DAF-16/FOXO by reactive oxygen species contributes to longevity in long-lived mitochondrial mutants in Caenorhabditis elegans
por: Senchuk, Megan M., et al.
Publicado: (2018)

Modeling Parkinson’s Disease in C. elegans
por: Cooper, Jason F., et al.
Publicado: (2018)

Identification of Novel Therapeutic Targets for Polyglutamine Diseases That Target Mitochondrial Fragmentation
por: Traa, Annika, et al.
Publicado: (2021)

Novel animal model defines genetic contributions for neuron-to-neuron transfer of α-synuclein
por: Tyson, Trevor, et al.
Publicado: (2017)

LRRK2 and Protein Aggregation in Parkinson’s Disease: Insights From Animal Models
por: Dues, Dylan J., et al.
Publicado: (2020)

Deletion of the Mitochondrial Superoxide Dismutase sod-2 Extends Lifespan in Caenorhabditis elegans
por: Van Raamsdonk, Jeremy M., et al.
Publicado: (2009)

Effect of DMSO on lifespan and physiology in C. elegans : Implications for use of DMSO as a solvent for compound delivery
por: AlOkda, Abdelrahman, et al.
Publicado: (2022)

Neuroprotective Effects of Betulin in Pharmacological and Transgenic Caenorhabditis elegans Models of Parkinson’s Disease
por: Tsai, Chia-Wen, et al.
Publicado: (2018)

Synthesis of Melatonin Derivatives and the Neuroprotective Effects on Parkinson’s Disease Models of Caenorhabditis elegans
por: He, Li, et al.
Publicado: (2022)

Neuroprotective Effects of the Cultivated Chondrus crispus in a C. elegans Model of Parkinson’s Disease
por: Liu, Jinghua, et al.
Publicado: (2015)

Astaxanthin is neuroprotective in an aged mouse model of Parkinson’s disease
por: Grimmig, Beth, et al.
Publicado: (2017)

Genetics of Aging in Caenorhabditis elegans
por: Antebi, Adam
Publicado: (2007)

Ferulic Acid Exerts Neuroprotective Effects via Autophagy Induction in C. elegans and Cellular Models of Parkinson's Disease
por: Long, Tao, et al.
Publicado: (2022)

Microglial Ion Channels as Potential Targets for Neuroprotection in Parkinson's Disease
por: Richardson, Jason R., et al.
Publicado: (2013)

Nobiletin Delays Aging and Enhances Stress Resistance of Caenorhabditis elegans
por: Yang, Xueyan, et al.
Publicado: (2020)

Biological Aging and the Cellular Pathogenesis of Huntington’s Disease
por: Machiela, Emily, et al.
Publicado: (2020)

Neurodegeneration and neuroprotection in Parkinson's disease /
Publicado: (1996)

Oolonghomobisflavans exert neuroprotective activities in cultured neuronal cells and anti-aging effects in Caenorhabditis elegans
por: Zhang, Shaoxiong, et al.
Publicado: (2022)

Neuroprotective Function of DJ-1 in Parkinson's Disease
por: Ariga, Hiroyoshi, et al.
Publicado: (2013)

Neuroprotective potential of Cannabis sativa-based oils in Caenorhabditis elegans
por: Vanin, Ana Paula, et al.
Publicado: (2022)

The Promise of Neuroprotective Agents in Parkinson’s Disease
por: Seidl, Stacey E., et al.
Publicado: (2011)

Neuroprotection in Parkinson’s disease: facts and hopes
por: Salamon, András, et al.
Publicado: (2019)

A cellular surveillance and defense system that delays aging phenotypes in C. elegans
por: Hahm, Jeong-Hoon, et al.
Publicado: (2020)

Inhibition of PAR-1 delays aging via activating AMPK in C. elegans
por: Wu, Di, et al.
Publicado: (2020)

From the bench to the bedside: Emerging science in Parkinson’s disease, cholesterol metabolism, and neuroprotection
por: Hauptman, Jason S.
Publicado: (2010)

Caffeine extends life span, improves healthspan, and delays age-associated pathology in Caenorhabditis elegans
por: Sutphin, George L, et al.
Publicado: (2012)

The Mitochondria-Regulated Immune Pathway Activated in the C. elegans Intestine Is Neuroprotective
por: Chikka, Madhusudana Rao, et al.
Publicado: (2016)

Time to Surgery and Survival in Head and Neck Cancer
por: Heft Neal, Molly E., et al.
Publicado: (2020)

Increase of Reproductive Life Span Delays Age of Onset of Parkinson’s Disease
por: Frentzel, Dominik, et al.
Publicado: (2017)

Medical Management of Parkinson’s Disease: Focus on Neuroprotection
por: Boll, Marie-Catherine, et al.
Publicado: (2011)

Neuroprotection by Nrf2 in Parkinson’s disease model
Publicado: (2011)

Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection
por: Mounsey, Ross B., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_p354s6gn8hngtrufg98obibh5i